Projects per year
Search results
-
Active
Development of novel PAR2 antagonists to treat inflammatory disease
5/02/23 → 29/08/27
Project: Research
-
Developing novel inhibitors to prevent the induction of CXCL12 in breast cancer fibroblasts cells
28/01/23 → 29/01/28
Project: Internally funded project
-
Evaluation of protease activated receptor 2 (PAR2) as a novel therapeutic target for chronic obstructive pulmonary disease (COPD)
Crilly, A. & McIntosh, K.
17/10/22 → 31/10/25
Project: Research - Studentship
-
TAK-1 inhibition prevents cytokine-mediated CXCL12 production in a bone cancer cell line
1/04/21 → 31/10/24
Project: Research - Studentship
-
Finished
Development and preclinical validation of novel PAR2 inhibitors for the treatment of Osteoarthritis
McIntosh, K., Crilly, A., Jamieson, C., Plevin, R. & Rattray, Z.
1/04/20 → 30/09/22
Project: Research
-
Preventing the damaging effects of cancer chemotherapy and radiation treatment on human endothelial cells targeting the JNK pathway
Plevin, R., Boyd, M. & McIntosh, K.
1/04/19 → 31/08/23
Project: Research - Studentship
-
Inhibition of human CXCL12 expression by novel inhibitory kappa B kinase alpha compounds - a novel approach for new drug development in breast cancer
McIntosh, K. & Patton, C.
8/10/18 → 31/12/21
Project: Internally funded project
-
Investigating the role of the non-canconical arm of the NFkB pathway in pancreatic cancer, utilising novel inhibitory compounds.
1/10/18 → 2/09/19
Project: Internally funded project
-
Preclinical validation of novel PAR-2 inhibitors for the treatment of Osteoarthritis and Cancer
1/02/14 → 30/09/15
Project: Research
-
Purinergic regulation of JNK signalling in cancer cells - novel modulation of proliferative capacity by GPCRs. (£1,850)
27/05/13 → 27/09/13
Project: Research